The spectrum of polycystic kidney disease in children

Katherine MacRae Dell1

  • 1Division of Pediatric Nephrology, Department of Pediatrics, Rainbow Babies and Children's Hospital and Case Western Reserve University, Cleveland, OH 44106, USA. Katherine.Dell@case.edu

Insights

Autosomal dominant polycystic kidney disease (ADPKD) and autosomal recessive polycystic kidney disease (ARPKD) can affect both children and adults, sharing cilia dysfunction. While ADPKD is systemic, ARPKD primarily impacts kidneys and liver, with liver complications increasing in adult survivors.

Area of Science:

  • Nephrology
  • Genetics
  • Pediatric Medicine

Background:

  • Autosomal dominant polycystic kidney disease (ADPKD) and autosomal recessive polycystic kidney disease (ARPKD) are inherited kidney disorders.
  • Both ADPKD and ARPKD, previously thought to be age-specific, can manifest in children and adults.
  • Cilia dysfunction is a shared pathophysiological feature in ADPKD and ARPKD.

Purpose of the Study:

  • To delineate the distinct clinical features and genetic underpinnings of ADPKD and ARPKD.
  • To clarify the age of presentation and common symptoms for both ADPKD and ARPKD.
  • To highlight the systemic nature of ADPKD versus the organ-specific involvement in ARPKD.

Main Methods:

  • Review of clinical and genetic data for ADPKD and ARPKD patients.
  • Analysis of disease presentation across different age groups.
  • Comparison of pathophysiological mechanisms, including cilia function.

Main Results:

  • ADPKD presents systemically with kidney and abdominal cysts, and cardiac/vascular abnormalities, with pediatric cases often asymptomatic or presenting with hypertension/hematuria.
  • ARPKD is characterized by polycystic kidneys and congenital hepatic fibrosis, with infantile presentations common but later childhood/adult onset linked to liver complications.
  • Routine screening for renal cysts in asymptomatic children with a family history of ADPKD is generally not advised.

Conclusions:

  • ADPKD and ARPKD exhibit varied presentations across the lifespan, challenging traditional age-based classifications.
  • Understanding the distinct genetic and clinical profiles of ADPKD and ARPKD is crucial for accurate diagnosis and management.
  • Increasing survival in ARPKD patients necessitates greater awareness of potential adult-onset liver complications.

Related Concept Videos

Nephrons01:10

Nephrons

The kidneys are intricate organs with millions of working units known as nephrons. Each nephron features two major structures: the renal corpuscle, which facilitates blood plasma filtration, and the renal tubule, which handles the glomerular filtrate. Blood supply is directly linked to the nephrons. The renal corpuscle consists of the glomerulus, a capillary network, and the Bowman's capsule, a double-walled epithelial structure that encases the glomerulus. The filtering of blood plasma happens...
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of fluid...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...